Preeclampsia clinical trials
55 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia
- MitoQ to Improve Vascular Funciton in Preeclampsia
- Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
- Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
- The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
- Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
- Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
- Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
- Aspirin for Postpartum Patients With Preeclampsia
- Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
- Mobile Health Program for Post-Preeclampsia Hypertension
- A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
- Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
- MOMs Chat and Care Study
- Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
- Physical Activity to Mitigate PreEclampsia Risk
- APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- Aspirin and Preeclampsia
- Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study
- Postpartum Low-Dose Aspirin and Preeclampsia
- Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
- Aspirin Dosing in Pregnancy
- Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies
- Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- The Mom and Infant Outcomes (MOMI) Study
- Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia
- Non-Invasive Preeclampsia Screening and Biobank
- EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)
- Exosome Cargo From Preeclampsia Patients
- Mechanisms of Pregnancy Vascular Adaptations
- Cardiometabolic Disease and Substrate Metabolism
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- Exercise Testing After Preeclampsia
- The Preeclampsia Registry
- Multi-Omics for Maternal Health After Preeclampsia
- Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women
- Prenatal Aspirin and Postpartum Vascular Function
- Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
- Treatment With Aspirin After Preeclampsia: TAP Trial
- Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
- Predictors of Aspirin Failure in Preeclampsia Prevention
- Vascular Effects of High-Salt After Preeclampsia
- Daily Aspirin Treatment After Preeclampsia
- Biomarkers in Management of Post Partum Preeclampsia
- A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
- Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
- Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia Prevention
- Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
- Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal Anesthesia
- Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Preeclampsia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.